Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Details) - Schedule of Outstanding Shares of Potentially Dilutive Securities Were Excluded From the Computation of Diluted Net Loss Per Share

v3.23.3
Net Loss Per Share (Details) - Schedule of Outstanding Shares of Potentially Dilutive Securities Were Excluded From the Computation of Diluted Net Loss Per Share - shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Schedule of Outstanding Shares of Potentially Dilutive Securities Were Excluded From the Computation of Diluted Net Loss Per Share [Abstract]        
Options to purchase common stock 10,321,616 1,165,397 10,321,616 1,165,397
Warrants to purchase common stock 4,784,193 4,784,193 4,784,193 4,784,193
Warrants to purchase convertible preferred stock 160,958,167 160,958,167
Total 176,063,976 5,949,590 176,063,976 5,949,590